Total Payments
$21,086
2024 Payments
$2,358
Companies
59
Transactions
1,500
Medicare Patients
3,015
Medicare Billing
$194,353
Payment Breakdown by Category
Food & Beverage$21,035 (99.8%)
Education$50.45 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,035 | 1,493 | 99.8% |
| Education | $50.45 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,433 | 213 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,204 | 88 | $0 (2024) |
| Amgen Inc. | $1,727 | 120 | $0 (2024) |
| Lilly USA, LLC | $1,703 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,671 | 110 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $1,664 | 116 | $0 (2023) |
| ABBVIE INC. | $1,099 | 91 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,030 | 100 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $830.07 | 48 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $742.10 | 46 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,358 | 134 | Lilly USA, LLC ($370.32) |
| 2023 | $1,998 | 120 | AstraZeneca Pharmaceuticals LP ($256.36) |
| 2022 | $2,121 | 150 | ABBVIE INC. ($238.92) |
| 2021 | $3,140 | 229 | AstraZeneca Pharmaceuticals LP ($378.32) |
| 2020 | $2,367 | 185 | Novo Nordisk Inc ($368.69) |
| 2019 | $2,890 | 209 | Novo Nordisk Inc ($375.44) |
| 2018 | $2,468 | 214 | AstraZeneca Pharmaceuticals LP ($277.90) |
| 2017 | $3,744 | 259 | SANOFI-AVENTIS U.S. LLC ($516.73) |
All Payment Transactions
1,500 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Insomnia | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/22/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Cardiovascular Diseases | ||||||
| 11/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Insomnia | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Biological | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Insomnia | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Gastroenterology | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 711 | 928 | $350,715 | $39,497 |
| 2022 | 8 | 801 | 998 | $362,839 | $45,712 |
| 2021 | 9 | 741 | 892 | $391,106 | $42,297 |
| 2020 | 9 | 762 | 1,152 | $174,294 | $66,847 |
Total Patients
3,015
Total Services
3,970
Medicare Billing
$194,353
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 254 | $101,574 | $11,347 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 223 | $125,498 | $10,143 | 8.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 88 | 91 | $25,480 | $6,453 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $69,531 | $5,787 | 8.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 91 | 95 | $9,869 | $3,091 | 31.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 27 | 29 | $11,664 | $1,788 | 15.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 94 | 100 | $6,911 | $836.17 | 12.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 15 | $188.00 | $51.15 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 225 | $126,473 | $12,103 | 9.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 211 | $84,478 | $9,694 | 11.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 108 | 109 | $26,596 | $7,327 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 138 | 138 | $79,416 | $7,261 | 9.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 50 | 62 | $24,676 | $4,081 | 16.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 114 | 115 | $11,845 | $3,709 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 122 | 125 | $8,016 | $1,112 | 13.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $1,339 | $426.21 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 216 | $136,786 | $11,177 | 8.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 158 | $67,072 | $7,372 | 11.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 126 | 126 | $92,250 | $6,766 | 7.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 99 | 99 | $24,156 | $6,461 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 60 | 77 | $38,945 | $5,186 | 13.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 17 | 22 | $12,772 | $2,435 | 19.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 104 | 104 | $10,712 | $1,958 | 18.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 71 | 77 | $6,442 | $693.95 | 10.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $1,971 | $247.29 | 12.5% |
About Sofia Mavasheva
Sofia Mavasheva is a Internal Medicine healthcare provider based in Trenton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851345995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sofia Mavasheva has received a total of $21,086 in payments from pharmaceutical and medical device companies, with $2,358 received in 2024. These payments were reported across 1,500 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($21,035).
As a Medicare-enrolled provider, Mavasheva has provided services to 3,015 Medicare beneficiaries, totaling 3,970 services with total Medicare billing of $194,353. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Trenton, NJ
- Active Since 05/22/2006
- Last Updated 06/24/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1851345995
Products in Payments
- JARDIANCE (Drug) $1,570
- Livalo (Drug) $1,525
- Ozempic (Drug) $824.54
- TRULICITY (Drug) $784.30
- FARXIGA (Drug) $767.08
- Vascepa (Drug) $698.58
- XARELTO (Drug) $691.95
- AIRSUPRA (Drug) $593.20
- VRAYLAR (Drug) $509.44
- Saxenda (Drug) $475.30
- Otezla (Drug) $425.34
- Repatha (Biological) $421.33
- Prolia (Biological) $395.14
- TRELEGY ELLIPTA (Drug) $364.52
- JANUVIA (Drug) $348.75
- PRALUENT (Drug) $346.63
- BREZTRI (Drug) $346.23
- Aimovig (Biological) $326.32
- QUVIVIQ (Drug) $311.72
- XIFAXAN (Drug) $306.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Trenton
Dr. Jane Rohlf, Md, MD
Internal Medicine — Payments: $66,501
Internal Medicine $66,501
Dr. Edward Laub, M.d, M.D
Internal Medicine — Payments: $49,453
Internal Medicine $49,453
Dr. Anuj Chandra, M.d, M.D
Internal Medicine — Payments: $19,972
Internal Medicine $19,972
Iradj Sharim, M.d, M.D
Internal Medicine — Payments: $14,940
Internal Medicine $14,940
Nilesh Rana, Md, MD
Internal Medicine — Payments: $11,392
Internal Medicine $11,392
Dr. Pavela Saha, Md, MD
Internal Medicine — Payments: $11,258
Internal Medicine $11,258